Tocagen (NASDAQ: TOCA) reported Q2 EPS of ($0.56), $0.04 worse than the analyst estimate of ($0.52). Revenue for the quarter came in at $10 thousand versus the consensus estimate of $10 thousand.

For earnings history and earnings-related data on Tocagen (TOCA) click here.